Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2002
12/17/2002US6495517 Cyclooxygenase inhibitor
12/17/2002US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002US6495376 Phosphoserine and phosphothreonine binding modules. the ww-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that
12/17/2002US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
12/17/2002US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting
12/17/2002US6495148 High molecular weight polyuronic acids used as moisturizers and for prevention of skin disorders, ulcers, wrinkles, dryness or aging
12/17/2002US6495135 Immortalized human keratinocyte cell line
12/17/2002CA2214439C A novel growth factor and a genetic sequence encoding same
12/17/2002CA2108977C Luteinizing hormone releasing hormone antagonist peptides
12/17/2002CA2080260C Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof
12/17/2002CA2052745C Process for the preparation of carnosic acid and the use of the acid for its anticarcinogenic and antiviral properties
12/14/2002CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/13/2002WO2001096575A1 Ceramide kinase and dna encoding the same
12/13/2002CA2412876A1 Ceramide kinase and dna encoding the same
12/12/2002WO2002099438A2 Modulation of steroid hormone uptake
12/12/2002WO2002099427A1 Srpks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099426A1 Pecis as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099140A1 GLRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099138A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099125A1 PIBs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099122A1 Modifiers of the p53 pathway and methods of use
12/12/2002WO2002099115A2 Nucleic acid-associated proteins
12/12/2002WO2002099110A1 Cell cycle regulatory factor
12/12/2002WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002WO2002099090A1 Bcl-2 dnazymes
12/12/2002WO2002099083A2 Gfats as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099068A2 Lces as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099059A2 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099058A2 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099057A2 Sams modifiers of the p53 pathway and methods of use
12/12/2002WO2002099056A2 C22c7orfs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099055A2 Cips as modifiers of the p53 pathway and method of use
12/12/2002WO2002099054A2 Hccss as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099053A2 Slc22as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099052A2 Opns as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099051A2 Nits as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099050A2 Tprs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099049A2 Tbc1d1s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099048A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099047A2 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099046A2 Spo11 as modifier of the p53 pathway and methods of use
12/12/2002WO2002099044A2 B3galts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099043A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099042A2 Cads as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099041A2 Ces2s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099038A2 Adsls as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098920A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002WO2002098918A2 Novel targets for a therapeutic intervention in ebv related diseases
12/12/2002WO2002098916A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002WO2002098907A2 Cation conducting gabaa receptors and their use
12/12/2002WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098898A2 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098897A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002WO2002098891A2 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098890A2 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098889A2 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002WO2002098883A1 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
12/12/2002WO2002098882A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
12/12/2002WO2002098881A1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative
12/12/2002WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002WO2002098877A1 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
12/12/2002WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002WO2002098868A1 Epothilone derivatives
12/12/2002WO2002098858A1 Integrin antagonists
12/12/2002WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002WO2002098843A2 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
12/12/2002WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002WO2002098511A1 Compositions comprising oestrone-3-0-sulphamate and trail (tnf-related apoptosis inducing ligand)
12/12/2002WO2002098501A2 Method and apparatus for treating tumors using low strength electric fields
12/12/2002WO2002098482A2 System for osmotic delivery of pharmaceutically active agents
12/12/2002WO2002098468A1 SLC13As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098467A1 Slc2as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098458A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
12/12/2002WO2002098450A1 Altering an immune response by influencing the interaction of lair with its ligand
12/12/2002WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
12/12/2002WO2002098443A2 Stabilised mrna with an increased g/c content and optimised codon for use in gene therapy
12/12/2002WO2002098438A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
12/12/2002WO2002098437A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002WO2002098426A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
12/12/2002WO2002098424A1 Novel anti-infectives
12/12/2002WO2002098422A1 Use of methylnaltrexone to treat immune suppression
12/12/2002WO2002098417A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
12/12/2002WO2002098416A2 Antineoplastic combinations
12/12/2002WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002WO2002098399A2 Cancer treatment method and compositions comprising compounds of the ginger family
12/12/2002WO2002098369A2 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002WO2002098368A2 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
12/12/2002WO2002098362A2 Use of rank antagonists to treat cancer
12/12/2002WO2002098360A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/12/2002WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098351A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
1 ... 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 ... 2211